Hermetica Superfood Encyclopedia
Centaurium erythraea is a bitter herb containing secoiridoid glycosides like gentiopicroside that stimulate digestive secretions. These compounds activate bitter taste receptors to enhance gastric acid production and bile flow, supporting traditional use for digestive disorders.


Centaurium erythraea (Common Centaury) is a perennial herb native to Europe, particularly the Mediterranean region, and naturalized in North America, belonging to the Gentianaceae family. The medicinal part consists of dried aerial parts harvested during bloom, typically prepared as comminuted herb for tea or ethanol-based tinctures. It is characterized by its rich content of secoiridoid glucosides (bitter principles), xanthones, phenolic acids, and triterpenoids.
No human clinical trials, RCTs, or meta-analyses for Centaurium erythraea were identified in the research. The herb appears in EU-authorized combination products (containing 18 mg pulverized centaury) for digestive indications, but these rely on traditional use rather than clinical trial data.

No clinically studied dosage ranges are available due to absence of human trials. Traditional preparations include comminuted herbal substance for tea (dose unspecified) and combination coated tablets containing 18 mg pulverized centaury. Some formulations use ethanol 59% as extraction solvent. Consult a healthcare provider before starting any new supplement.
Centaurium erythraea is not consumed as a food in meaningful caloric quantities; it is used as a medicinal herb, typically as infusions, tinctures, or powdered extracts, so macronutrient contribution (protein, fat, carbohydrate) is negligible in practice. Its value lies in its bioactive phytochemical profile: **Secoiridoid glycosides (bitter compounds, primary actives):** • Swertiamarin – typically 1–6% of dry herb weight; major bitter principle responsible for digestive and appetite-stimulating effects • Gentiopicroside (gentiopicrin) – approximately 0.5–2% of dry weight; intensely bitter secoiridoid also found in Gentiana spp. • Sweroside – present at lower concentrations (~0.1–1%); contributes to overall bitter index • Centapicrin and desacetylcentapicrin – trace to minor amounts; highly bitter secoiridoid lactones • Overall bitter value of the herb is rated at approximately 3,500–12,000 (European Pharmacopoeia standard), among the most bitter of European medicinal plants **Xanthones:** • Eustomin, demethyleustomin, methylbellidifolin – collectively ~0.1–0.3% of dry weight • 1-Hydroxy-3,5,6,7-tetramethoxyxanthone and related derivatives • These xanthones are responsible for much of the demonstrated in vitro antioxidant activity (hydroxyl radical scavenging, HOCl scavenging); bioavailability in humans is poorly characterized **Phenolic acids and flavonoids:** • Protocatechuic acid, sinapic acid, ferulic acid, caffeic acid – present in small quantities (exact concentrations vary by harvest and preparation) • Flavonoids including quercetin, kaempferol, and luteolin glycosides – estimated at ~0.2–0.5% total flavonoid content • These contribute additional antioxidant capacity (DPPH and ABTS radical scavenging demonstrated in vitro) **Triterpenoids and phytosterols:** • Oleanolic acid, β-sitosterol, stigmasterol, erythrodiol – minor constituents present in aerial parts • Ursolic acid – trace amounts **Essential oil (trace, <0.1%):** • Monoterpenes and sesquiterpenes in very low concentrations; not a significant source of volatile compounds **Alkaloids:** • Gentianine and gentianidine – trace pyridine alkaloids (~0.01–0.05%); pharmacological significance at typical doses is uncertain **Minerals and vitamins:** • Not a significant dietary source of vitamins or minerals given typical dosing (1–4 g dried herb per day as infusion) • Some analyses report presence of potassium, calcium, magnesium, iron, and manganese, but quantities per dose are nutritionally trivial • No meaningful vitamin content has been documented **Fiber/Carbohydrates:** • Dried herb contains typical plant cell wall polysaccharides but given dose sizes (1–4 g), fiber contribution is negligible **Bioavailability notes:** • Swertiamarin and gentiopicroside are water-soluble glycosides well-extracted by hot water infusion (tea) or hydroalcoholic tincture (60–70% ethanol extracts optimally) • Bitter taste receptor activation (TAS2R receptors) occurs in the oral cavity upon ingestion, so systemic absorption is not strictly required for appetite-stimulating effects • Xanthones are relatively lipophilic; their oral bioavailability is likely limited, and most antioxidant data are from in vitro studies only • Secoiridoid aglycones may be released by gut microbial hydrolysis, but human pharmacokinetic data for centaury compounds are essentially absent • Traditional preparation as a cold or warm water infusion (1.5–3 g herb per 150 mL, steeped 10–15 minutes) is considered the standard method and likely provides adequate extraction of water-soluble bitter glycosides
Centaurium erythraea's secoiridoid glycosides, particularly gentiopicroside and sweroside, activate bitter taste receptors (TAS2Rs) on enteroendocrine cells. This stimulation triggers release of gastrin and cholecystokinin, promoting gastric acid secretion and bile flow. The herb's phenolic compounds including caffeic acid derivatives scavenge hydroxyl radicals and hypochlorous acid, contributing to antioxidant effects.
Clinical evidence for Centaurium erythraea remains limited to traditional use and preliminary laboratory studies. In vitro research demonstrates antioxidant activity through hydroxyl radical and hypochlorous acid scavenging, but human trials are lacking. Traditional evidence supports digestive benefits for indigestion and appetite loss, though controlled studies have not validated these effects. Most evidence consists of phytochemical analysis and traditional use documentation rather than rigorous clinical data.
Centaurium erythraea is generally considered safe when used traditionally as a bitter tonic. The herb may increase gastric acid production, potentially contraindicated in peptic ulcer disease or gastroesophageal reflux. No significant drug interactions are documented, though theoretical concerns exist with acid-blocking medications due to opposing mechanisms. Safety during pregnancy and lactation has not been established, warranting caution in these populations.